The FDA-approved anti-cancer drug, nilotinib improves astroglial bioenergetics in Alzheimer’s disease

Research output: Contribution to conference › Abstract

Original language	American English
State	Published - 2019
Event	Canadian Association for Neuroscience (CAN)-ACN - Toronto, Canada Duration: May 22 2019 → May 25 2019

Conference	Canadian Association for Neuroscience (CAN)-ACN
Country/Territory	Canada
City	Toronto
Period	5/22/19 → 5/25/19

Cite this

@conference{7e904a2629124b4683bf6eb9a1ba8b64,

title = "The FDA-approved anti-cancer drug, nilotinib improves astroglial bioenergetics in Alzheimer{\textquoteright}s disease",

author = "Benedict Albensi and Aida Adlimoghaddam and Turner, \{R. Scott\}",

year = "2019",

language = "American English",

note = "Canadian Association for Neuroscience (CAN)-ACN ; Conference date: 22-05-2019 Through 25-05-2019",

}